Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

What's New in Treatment Information?

Excerpts from Hotline Memos of April 2002
from the Information Department of Project Inform

May 2002

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Expanded Access Program for Atazanavir

Bristol-Myers Squibb, the developer of a once-daily protease inhibitor, atazanavir, will start the first phase of a large expanded access program around May 15.

To qualify, people must meet the following criteria:

  • be 16 or older
  • a viral load over 5,000 while on HAART
  • CD4+ count below 300
  • Unable to construct a HAART regimen due to one or more of the following:
    • Previous treatment failure on HAART
    • Significantly high triglycerides or lipids
    • Other toxicity or intolerance, as defined by the protocol
    • Drug-drug interaction

    or

    • HAART-related high lipid levels that are unresponsive to lipid-lowering agents, regardless of viral load or CD4+ count

Some exclusions will also affect applicants, including:

  • Current use of Kaletra, Crixivan or Sustiva (due to lack of drug interaction)
  • Underlying heart disease or irregular heart beat

Advertisement
The requirements may change over the course of the program as new information becomes available. To register patients in the program, physicians should call 1-877-726-7327.


A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by Project Inform. It is a part of the publication What's New. Visit Project Inform's website to find out more about their activities, publications and services.
 
See Also
More on Paying for HIV/AIDS Medications

Tools
 

Advertisement